As Congress barrels toward passage of the 21st Century Cures Act, it has failed to ask a crucial question: Will it help or harm the nation's drive to derive greater value from its healthcare dollars?
Successful population health management will require a lot more from the nation's healthcare leaders than merely revamping their systems' delivery models—as difficult as that will be.
Medicare's 32 Pioneer accountable care organizations posted mixed results after two years, revealing once again that making money from care coordination is proving a heavy lift for most provider organizations.
Proposed legislation “modernizing” the Food and Drug Administration's approach to approving breakthrough drugs and devices would undermine the agency's ability to protect the American public from unproven and possibly unsafe new products.
Every year, more than a million children under age 3 undergo operations in the nation's hospitals using anesthetics that the Food and Drug Administration and many clinical scientists fear may be damaging their developing brains.
Most Americans who receive care at more than one location still don't have their “complete” record in front of their attending physician. Heck, most providers can't or won't even send their patients' electronic records across town, much less to a neighboring state or across the country.
The Medicare SGR replacement bill that most likely will pass Congress this week makes sweeping changes to Medicare's programs for rewarding or penalizing physicians on quality, cost and their adoption of EHRs. It also gives medical specialty boards an unwarranted role in how those rewards or...
Idaho, famous for its pine forests, crystalline lakes and baking potatoes, has a scant 1.6 million people spread over its 82,643 square miles. Yet it has seized center stage in setting national healthcare economic policy.
The incentives in the permanent “doc-fix” legislation, which now has overwhelming bipartisan support from both houses of Congress and the president, will not, by themselves, drive physicians toward value-based compensation schemes.
With the GOP holding 24 of 34 Senate seats up for grabs in the next election, the Republican-controlled Senate wisely snubbed the House-backed budget resolution last week.
Over the past two years, conventional wisdom presumed without offering much in the way of evidence that the lingering recession and the rise of high-deductible and narrow network plans explained the slowdown in healthcare spending, now in its fifth year.
Financial markets have sent another signal that the coming era of precision or personalized medicine could wind up making cancer care unaffordable for millions of people.